Global Artemisinin Combination Therapy Market to Witness Significant Rise in Revenue During 2018 - 2028
The World Health Organization (WHO) has adopted artemisinin combination therapy as the first line of treatment for uncomplicated malaria caused by Plasmodium falciparum. Today, artemisinin combination therapy is the most effective available antimalarial medicines by combining 2 active ingredients of different mechanisms of action. The WHO has recommended 5 artemisinin combination therapy for malaria caused by Plasmodium falciparum. The selection of artemisinin combination therapy based on the results obtained from therapeutic efficacy studies compared to Plasmodium falciparum malaria local strains....
View full press release